These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7626293)

  • 21. [Adenocarcinoma in Barrett's esophagus. A retrospective study of 46 patients followed during 3.5 years].
    Bujanda Fernández de Piérola L; Muñoz Villafranca C; Sánchez Martínez A; Iriondo Martínez de Luco C; Aras Portilla LM
    An Med Interna; 1999 Apr; 16(4):178-80. PubMed ID: 10339842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barrett's esophagus (BE) and carcinoma in the esophageal stump (ES) after esophagectomy with gastric pull-up in achalasia patients: a study based on 10 years follow-up.
    da Rocha JR; Ribeiro U; Sallum RA; Szachnowicz S; Cecconello I
    Ann Surg Oncol; 2008 Oct; 15(10):2903-9. PubMed ID: 18618179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms.
    Toruner M; Soykan I; Ensari A; Kuzu I; Yurdaydin C; Ozden A
    J Gastroenterol Hepatol; 2004 May; 19(5):535-40. PubMed ID: 15086597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
    Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
    Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender differences in the age-stratified prevalence of erosive esophagitis and Barrett's epithelium in Japan.
    Akiyama T; Inamori M; Akimoto K; Iida H; Mawatari H; Endo H; Nozaki Y; Yoneda K; Sakamoto Y; Ikeda T; Fujita K; Yoneda M; Takahashi H; Goto A; Abe Y; Kirikoshi H; Kobayashi N; Kubota K; Saito S; Nakajima A
    Hepatogastroenterology; 2009; 56(89):144-8. PubMed ID: 19453046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylene blue chromoendoscopy for the detection of Barrett's esophagus in a Greek cohort.
    Kouklakis GS; Kountouras J; Dokas SM; Molyvas EJ; Vourvoulakis GP; Minopoulos GI
    Endoscopy; 2003 May; 35(5):383-7. PubMed ID: 12701007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barrett's esophagus: prevalence in symptomatic relatives.
    Romero Y; Cameron AJ; Schaid DJ; McDonnell SK; Burgart LJ; Hardtke CL; Murray JA; Locke GR
    Am J Gastroenterol; 2002 May; 97(5):1127-32. PubMed ID: 12017151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidemiology and pathophysiology of Barrett esophagus].
    Freys SM; Fuchs KH; Heimbucher J; Fein M; Thiede A
    Zentralbl Chir; 2000; 125(5):406-13. PubMed ID: 10929624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short segment Barrett's esophagus: relationship of age with extent of intestinal metaplasia.
    Benipal P; Garewal HS; Sampliner RE; Martinez P; Hayden CW; Fass R
    Am J Gastroenterol; 2001 Nov; 96(11):3084-8. PubMed ID: 11721753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of Barrett's esophagus in the general population: an endoscopic study.
    Ronkainen J; Aro P; Storskrubb T; Johansson SE; Lind T; Bolling-Sternevald E; Vieth M; Stolte M; Talley NJ; Agréus L
    Gastroenterology; 2005 Dec; 129(6):1825-31. PubMed ID: 16344051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barrett's esophagus: a review.
    Gadour M; Ayoola EA
    Trop Gastroenterol; 2002; 23(4):157-61. PubMed ID: 12833699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Mulholland HG; Cantwell MM; Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; McGuigan J; Reynolds JV; Comber H; Murray LJ
    Cancer Causes Control; 2009 Apr; 20(3):279-88. PubMed ID: 18839322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis.
    Weston AP; Sharma P; Mathur S; Banerjee S; Jafri AK; Cherian R; McGregor D; Hassanein RS; Hall M
    Am J Gastroenterol; 2004 Sep; 99(9):1657-66. PubMed ID: 15330898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Barrett esophagus: epidemiologic data and risk of becoming malignant].
    García Marcilla JA; Parrilla Paricio P; Ortiz Escandell MA; Martínez de Haro LF; Aguado Albasini JL; Molina Martínez J; Rodríguez Bermejo M
    Rev Esp Enferm Apar Dig; 1989 Nov; 76(5):419-23. PubMed ID: 2694239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barrett's oesophagus: results from a 13-year surveillance programme.
    Bani-Hani K; Sue-Ling H; Johnston D; Axon AT; Martin IG
    Eur J Gastroenterol Hepatol; 2000 Jun; 12(6):649-54. PubMed ID: 10912484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: Barrett's oesophagus and carcinoma in Japan.
    Hongo M
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():50-4. PubMed ID: 15575874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.